Lilly' Bamlanivimab & Etesevimab Reduce Hospitalizations & Death In Phase 3 Trial For Early COVID-19
#lilly
#etesevimabreducehospitalizations
#early
3 years ago By Lawce — (RTTNews) - Eli Lilly and Co.'s (LLY) bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together significantly reduced COVID-19 related ho